Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

ClinicalTrials.gov ID: NCT05514548

Public ClinicalTrials.gov record NCT05514548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of Two Doses of INV-202 in Patients With Diabetic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due to either Type 1 diabetes mellitus or Type 2 diabetes mellitus.

Study identification

NCT ID
NCT05514548
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Inversago Pharma Inc.
Industry
Enrollment
265 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2022 (Actual)
Primary completion
Aug 20, 2024 (Actual)
Completion
Sep 3, 2024 (Actual)
Last update posted
Aug 11, 2025

2022 – 2024

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
National Institute of Clinical Research, Inc. Garden Grove California 92844 —
National Institute of Clinical Research, Inc - Pomona Pomona California 91768 —
Central Coast Nephrology Salinas California 93901 —
North American Research Institute San Dimas California 91773 —
National Institute of Clinical Research, Inc - Upland Upland California 91786 —
Research Physicians Network Alliance Boca Raton Florida 33431 —
ALL Medical Research, LLC Cooper City Florida 33024 —
South Florida Research Institute Lauderdale Lakes Florida 33313 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
Research by Design, LLC Chicago Illinois 60643 —
Endocrine and metabolic Consultants Rockville Maryland 20852 —
Clinical Research Consultants, LLC Kansas City Missouri 64111 —
Palm Research Center, Inc Las Vegas Nevada 89148 —
Physicians East, PA Greenville North Carolina 27834 —
Northeast Clinical Research Center Bethlehem Pennsylvania 18017 —
South Carolina Clinical Research LLC Orangeburg South Carolina 29118 —
Knoxville Kidney Center, Pllc Knoxville Tennessee 37923 —
North Texas Endocrine Center Dallas Texas 75231 —
Biopharma Informatic, LLC Houston Texas 77084 —
Linq Research, LLC Pearland Texas 77584 —
Linq Research, LLC Pearland Texas 77854 —
Clinical Advancement Center, PLLC San Antonio Texas 78212 —
University of Vermont Medical Center Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05514548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05514548 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →